AstraZeneca Holds Talks With Bristol Myers Squibb on $400 Billion Megadeal, FT Reports

3-line summary

• AstraZeneca is holding talks with Bristol Myers Squibb on a $400 billion megadeal, according to a Financial Times report.

This summary is our own processing of the source article; see the source link below for full context.